Waisman Biomanufacturing

Located at University of Wisconsin-Madison, Waisman Biomanufacturing provides specialized services for biotech companies and academic researchers. This includes manufacturing cGMP biotherapuetics for Phase I and Phase II clinical trials and guiding projects through the complex process mandated by the FDA for such trials.  

In 2022, Versa refreshed Waisman Biomanufacturing's look, creating an accessible, fast-loading site for mobile and desktop devices.